ZMAR vs. APXM
ZMAR (Innovator Equity Defined Protection ETF - 1 Yr March) and APXM (FT Vest U.S. Equity Max Buffer ETF - April) are both Defined Outcome funds. Both are actively managed. Over the past year, ZMAR returned 7.62% vs 5.49% for APXM. A 0.65 correlation means they provide meaningful diversification when combined. ZMAR charges 0.79%/yr vs 0.85%/yr for APXM.
Performance
ZMAR vs. APXM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ZMAR achieves a 2.66% return, which is significantly higher than APXM's 2.11% return.
ZMAR
- 1D
- -0.05%
- 1M
- 0.76%
- YTD
- 2.66%
- 6M
- 3.27%
- 1Y
- 7.62%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
APXM
- 1D
- -0.06%
- 1M
- 0.79%
- YTD
- 2.11%
- 6M
- 2.59%
- 1Y
- 5.49%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ZMAR vs. APXM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
ZMAR Innovator Equity Defined Protection ETF - 1 Yr March | 2.66% | 7.91% |
APXM FT Vest U.S. Equity Max Buffer ETF - April | 2.11% | 5.40% |
Correlation
The correlation between ZMAR and APXM is 0.64, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.64 |
Correlation (All Time) Calculated using the full available price history since Apr 22, 2025 | 0.65 |
The correlation between ZMAR and APXM has been stable across timeframes, ranging from 0.64 to 0.65 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ZMAR vs. APXM — Risk / Return Rank
ZMAR
APXM
ZMAR vs. APXM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Innovator Equity Defined Protection ETF - 1 Yr March (ZMAR) and FT Vest U.S. Equity Max Buffer ETF - April (APXM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ZMAR | APXM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.86 | ||
| Sortino ratioReturn per unit of downside risk | -4.67 | ||
| Omega ratioGain probability vs. loss probability | 1.84 | 2.60 | -0.76 |
| Calmar ratioReturn relative to maximum drawdown | 5.32 | 20.36 | -15.04 |
| Martin ratioReturn relative to average drawdown | 30.39 | 110.99 | -80.60 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ZMAR | APXM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.61 | 5.47 | -1.86 |
Sharpe Ratio (All Time)Calculated using the full available price history | 2.29 | 5.70 | -3.42 |
Drawdowns
ZMAR vs. APXM - Drawdown Comparison
The maximum ZMAR drawdown since its inception was -2.30%, which is greater than APXM's maximum drawdown of -0.40%. Use the drawdown chart below to compare losses from any high point for ZMAR and APXM.
Loading charts...
Drawdown Indicators
| ZMAR | APXM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -2.30% | -0.40% | -1.90% |
Max Drawdown (1Y)Largest decline over 1 year | -1.44% | -0.27% | -1.17% |
Current DrawdownCurrent decline from peak | -0.05% | -0.06% | +0.01% |
Average DrawdownAverage peak-to-trough decline | -0.23% | -0.03% | -0.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.25% | 0.05% | +0.20% |
Volatility
ZMAR vs. APXM - Volatility Comparison
The current volatility for Innovator Equity Defined Protection ETF - 1 Yr March (ZMAR) is 0.37%, while FT Vest U.S. Equity Max Buffer ETF - April (APXM) has a volatility of 0.42%. This indicates that ZMAR experiences smaller price fluctuations and is considered to be less risky than APXM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ZMAR | APXM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.37% | 0.42% | -0.05% |
Volatility (6M)Calculated over the trailing 6-month period | 1.57% | 0.78% | +0.79% |
Volatility (1Y)Calculated over the trailing 1-year period | 2.12% | 1.01% | +1.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 3.05% | 1.20% | +1.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 3.05% | 1.20% | +1.85% |
ZMAR vs. APXM - Expense Ratio Comparison
ZMAR has a 0.79% expense ratio, which is lower than APXM's 0.85% expense ratio.
Dividends
ZMAR vs. APXM - Dividend Comparison
Neither ZMAR nor APXM has paid dividends to shareholders.
Frequently Asked Questions
ZMAR and APXM have a correlation of 0.64, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
APXM has higher volatility (0.42%) compared to ZMAR (0.37%). In terms of maximum drawdown, ZMAR dropped -2.30% vs APXM's -0.40%.
On 1-year performance, ZMAR leads with 7.62% vs 5.49% for APXM. On fees, ZMAR is cheaper at 0.79% per year. Their volatility is very similar. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, ZMAR has performed better with a 7.62% return vs 5.49%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
ZMAR is cheaper with a 0.79% expense ratio, compared with 0.85% for APXM.
ZMAR and APXM have nearly identical dividend yields, around 0.00%.
They also come from different issuers: Innovator and First Trust. Their fees differ too: 0.79% for ZMAR and 0.85% for APXM.
APXM currently has the higher Sharpe Ratio (5.47 vs 3.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ZMAR and APXM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer